Related Experiment Video

Updated: Aug 17, 2026

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 11, 2013

Organ-directed toxicology of antitumor agents. Symposium summary

J S Lazo, M P Hacker

    Federation Proceedings
    |April 1, 1985
    PubMed

    Insights

    Antitumor drugs can harm specific organs. This review covers why this happens, the underlying mechanisms, and strategies to prevent or reduce drug-induced organ toxicities.

    Area of Science:

    • Oncology
    • Pharmacology
    • Toxicology

    Background:

    • Many anticancer agents exhibit significant organ-specific toxicities.
    • Understanding these toxicities is crucial for patient safety and treatment efficacy.

    Purpose of the Study:

    • To discuss the importance of organ toxicities caused by antitumor agents.
    • To explore the cellular and biochemical mechanisms underlying organ specificity.
    • To review methods for circumventing these adverse effects.

    Main Methods:

    • Literature review and synthesis of existing research on antitumor agent toxicity.
    • Analysis of cellular and biochemical pathways involved in organ damage.
    • Identification and evaluation of strategies to mitigate drug-induced toxicities.

    Main Results:

    • Antitumor agents can selectively damage organs through various mechanisms.
    • Organ specificity is determined by factors like drug metabolism, cellular targets, and repair pathways.
    • Several strategies, including dose modification and targeted interventions, can help manage toxicities.

    Conclusions:

    • Addressing organ-specific toxicities is essential for optimizing cancer therapy.
    • Further research into mechanisms and mitigation strategies can improve patient outcomes.
    • A comprehensive understanding aids in the development of safer and more effective antitumor treatments.

    More Related Videos

    Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation15:04

    Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

    Published on: January 19, 2019

    High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids06:25

    High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids

    Published on: June 14, 2021

    Related Concept Videos

    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
    Toxic Reactions: Overview01:26

    Toxic Reactions: Overview

    When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
    Toxicity falls into two primary categories: local and systemic.
    Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
    In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
    Mutagenicity and Carcinogenicity01:25

    Mutagenicity and Carcinogenicity

    Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
    Drug Toxicity: Overview01:00

    Drug Toxicity: Overview

    Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
    Drug Toxicity: Dose-Dependent Reactions01:24

    Drug Toxicity: Dose-Dependent Reactions

    Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
    Toxidromes: Clinical Features01:30

    Toxidromes: Clinical Features

    Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...